https://endpts.com/the-ema-gives-the-thumbs-down-to-gsks-bone-marrow-cancer-drug-ptcs-duchenne-candidate/
end points ( one word) dot com
PTC's DMD drug given the thumbs down by the EMA. Accelerated approval given in 2014. Its extension trial didnt provide statistically significant data showing benefit.
They are hoping patient groups will help overturn the decision.
For General Information, page-2957
-
- There are more pages in this discussion • 599 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
